Nuanced Marketing Considerations for Rare Diseases
Most pharmaceutical marketing can benefit from broad, one-size-fits-all messages being delivered to giant patient populations. Treatments for breast cancer, heart disease, diabetes and most other conditions that affect hundreds of thousands (or millions) of patients each year often fit into a pretty typical commercialization “template”. For orphan drugs used to treat rare diseases, you can pretty much throw any existing paradigm out the window.